DiagnosticImaging Members: Login | Register
Diagnostic Imaging Recommended Medical Sites Medline Drugs

Powered by SearchMedica

 
  • Home
  • Blog
  • Conference Reports
  • Case Studies
  • Jobs
  • Product Directory
  • Voice Recognition
  • Low Dose
  • RSNA 2011
  • PET-MR

Home » Conference Reports » ISMRM 2007

NewsfromISMRM2007

ISMRM 2007


View slide show

ISMRM2007


 

Danish study finds novel solution to problems in high-field MRI of brain

Philip Ward
May 23, 2007

The use of sensitivity encoding and a gradient echo sequence in dynamic susceptibility contrast (DSC) perfusion imaging at 3T leads to fewer artifacts and better diagnostic quality, according to award-winning research from Denmark.

DSC perfusion examinations at 3T are associated with pronounced artifacts close to tissue/bone and tissue/air interfaces, which mean that parts of the brain cannot be evaluated properly. Clinicians and researchers are reluctant to use this technique in conditions where these areas play an important role, such as Alzheimer's disease, stroke, epilepsy, and brain tumor.

To optimize DSC imaging at 3T, Anne Dorte Blankholm, a radiographer at the MR Centre in Aarhus University Hospital, Skejby, performed examinations on 12 healthy volunteers using a GE Signa HD machine. She presented details about her study in a special exhibition at the ISMRM-ESMRMB meeting organized by the Society of MR Technologists.

Six of the volunteers had a standard gradient echo (GRE) echo-planar imaging (EPI) perfusion sequence and a GRE EPI perfusion sequence during which the parallel imaging technique sensitivity encoding (SENSE/ASSET) was used. The other six had a GRE EPI perfusion examination and a spin echo (SE) EPI sequence.

An injection of Gadovist (gadobutrol, 604.72 mg/ml, 1 mmol/ml, Schering) was given in an antecubital vein. The first group of volunteers had an injection of 0.1 mmol/kg of body weight for each of the GRE sequences. The second group had 0.1 mmol/kg of body weight for the GRE sequence and 0.2 mmol/kg of body weight for the SE sequence.

The size of susceptibility artifacts was evaluated by measuring the area of visible brain for each sequence. On a GE Advanced Windows workstation, readers indicated by hand the area of visible brain, not including the susceptibility artifacts, on each slice in the series. The two-tailed t-test for matched pairs was used for statistical analysis. To assess the impact of the sequences on perfusion data, the signal-to-noise ratio was calculated in a region of interest containing both grey and white matter.

The diagnostic quality was evaluated by an experienced neuroradiologist, who rated the perfusion maps and the perfusion modulus images.

"The results showed that SENSE technology reduces susceptibility artifacts in DSC imaging at 3T," Blankholm noted. "Use of SENSE on the GRE perfusion sequence minimized susceptibility artifacts. The SNR and diagnostic quality increased when SENSE was used."

The results comparing the GRE and SE sequences showed that the SE displayed fewer susceptibility artifacts. There was no significant difference in SNR at baseline, and significant differences were found for SNR peak contrast where the GRE sequence displayed the best signal, according to Blankholm.

 

Join the Conversation

Want to join the conversation? Just sign in or register today to become part of our growing, online community.





Videos

Integration Relation: Jacques Coumans, VP of MR Marketing, Philips Medical Systems

Integration Relation: Jacques Coumans, VP of MR Marketing, Philips Medical Systems

Integration Relation: Jacques Coumans, vice president of MR marketing for Philips Medical Systems, explains how the company's acquisition last year of Intermagnetics, along with its subsidiary, Invivo, has simplified functional MR and how Philips' efforts to do so relate to its corporate policy of making sophisticated MR techniques easier to do. DI business editor Greg Freiherr has the report.
View video

 


MR Robot: Prof. Dr. Andreas Melzer, Co-Founder of InnoMedic

MR Robot: Prof. Dr. Andreas Melzer, Co-Founder of InnoMedic

MR Robot: Prof. Dr. Andreas Melzer, director of the Institute for Medical Sciences and Technology at the University of Dundee in Scotland and co-founder of InnoMedic, describes at the ISMRM meeting a robot designed for MR interventions. The device, now in clinical testing, takes cues from an MR scan to position a probe at an exact point and along a specific trajectory. DI business editor Greg Freiherr has the report.
View video

What'sNewonDiagnosticImaging


So, Imaging Technologist, You Want to Be Considered a Medical Professional
February 10, 2012
MRI Technique Shows Success of MS Drug Copaxone
February 9, 2012
Early CT Angiography Identifies Recurrent Stroke Risk
February 9, 2012
Podcast: Using MRI in the Operating Room
February 8, 2012
PET with FDG May Predict Outcomes in Triple-Negative Breast Cancer
February 8, 2012


CancerNetwork | CME LLC | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2012 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy